Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Contineum Therapeutics (CTNM) Return on Assets (2024 - 2025)

Historic Return on Assets for Contineum Therapeutics (CTNM) over the last 2 years, with Q3 2025 value amounting to 0.08%.

  • Contineum Therapeutics' Return on Assets rose 800.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.25% for FY2024, which is N/A changed from last year.
  • Contineum Therapeutics' Return on Assets amounted to 0.08% in Q3 2025, which was up 800.0% from 0.13% recorded in Q2 2025.
  • Over the past 5 years, Contineum Therapeutics' Return on Assets peaked at 0.15% during Q1 2024, and registered a low of 0.2% during Q4 2024.